Professional Documents
Culture Documents
Geneticvariation Published
Geneticvariation Published
net/publication/325779872
Genetic Variation
CITATIONS READS
0 1,986
2 authors:
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Bhagyalaxmi Mohapatra on 28 July 2018.
Genetic Variation, Table 1 List of bioinformatic tools and softwares to predict the pathogenicity of a missense genetic
variant
Tool Web address
AUTO-MUTE http://proteins.gmu.edu/automute/
Align-GVGD http://agvgd.hci.utah.edu/agvgd_input.php
CanPredict http://www.cgl.ucsf.edu/Research/genentech/canpredict
CADD http://cadd.gs.washington.edu/score
CONDEL http://bbglab.irbbarcelona.org/fannsdb/help/condel.html
FATHMM http://fathmm.biocompute.org.uk/
FunSAV http://sunflower.kuicr.kyoto-u.ac.jp/sjn/FunSAV/index.html
FuzzySnps http://rna.gmu.edu/FuzzySnps/
HANSA http://www.cdfd.org.in/HANSA/
I-Mutant2.0 http://folding.biofold.org/i-mutant/i-mutant2.0.html
LS-SNP http://ls-snp.icm.jhu.edu/ls-snp-pdb/
MAPP http://www.ngrl.org.uk/Manchester/page/mapp-multivariate-analysis-protein-polymorphism
Mutation assessor http://mutationassessor.org/r3/
MutationTaster http://www.mutationtaster.org/
MutPred2 http://mutpred.mutdb.org/
nsSNPAnalyzer http://snpanalyzer.uthsc.edu/
PhD-SNP http://snps.biofold.org/phd-snp/phd-snp.html
PMut http://mmb.irbbarcelona.org/PMut/
PolyPhen2 http://genetics.bwh.harvard.edu/pph2/
PROVEAN http://provean.jcvi.org/index.php
SAPRED https://omictools.com/sap-disease-association-predictor-tool
SIFT http://sift.jcvi.org/
SNAP http://www.bio-sof.com/snap
SNPs3D http://www.snps3d.org/
SNPs & GO https://snps-and-go.biocomp.unibo.it/snps-and-go/
SuSPect http://www.sbg.bio.ic.ac.uk/servers/suspect/about.html
translation of the gene is frame shifted or amino Copy Number Variations (CNV)
acids are deleted. For example, 3 bp deletion A CNV can be simple in structure, such as tandem
(DF508) in coding region of CFTR (cystic fibrosis duplication, or may involve complex gain and loss
transmembrane conductance regulator) gene is the of homologous sequences at multiple sites in the
most common cause of cystic fibrosis (Cutting genome. CNVs are genomic structural variants in
2015). However, nonpathogenic indel are often use- which the number of copies of a particular seg-
ful in mapping common ancestry in kinship and ment is different in two or more different genomes
human origin studies because chances of two muta- as compared to a reference genome.
tions of the same length occurring in the same
genomic position are negligible. Variable Number of Tandem Repeats (VNTRs)
These variations involve changes in the number of
Structural Variations repeated DNA sequences arranged in tandem
Structural variation refers to large-scale structural arrays.These are highly heterogeneous groups of
differences in the DNA, originated mainly due to loci. These are multiallelic markers while SNPs
chromosomal rearrangements – deletion, duplica- are generally biallelic. They are classified
tion, novel sequence insertion, or inversion. They according to the size and number of their repeat
include copy number variations, variable number of units. They are sometimes considered as neutral
tandem repeats, and chromosomal rearrangement. markers. But there are many instances among
4 Genetic Variation
Genetic Variation,
Fig. 1 List of techniques Hybridization based methods
used for detecting genetic • Dynamic allele specific hybridisation
variations
• Molecular beacons
alleles from several genes contributing to the dis- (PCR)-based technology which detects very
ease. Linkage and association studies are used to short polymorphic stretches of DNA.
conduct genetic tests for screening of diseases
which involves profiling of disease causing vari-
ants (Taylor et al. 2001).
Conclusion
Pharmacogenomics Subtle differences in DNA are the ultimate cause
GV in patients make them respond differently to a of genetic variation. They may include single-
medication. In the future, the most appropriate nucleotide polymorphisms, variable numbers of
drug for an individual could be determined in tandem repeats, and large-scale copy number var-
advance of treatment by analyzing a patient’s iants. Both inherited and denovo variations could
SNP profile and such kinds of treatment which be either advantageous or deleterious for an
are specific for an individual are called “personal- organism. Beneficial variations are selectively
ized medicines.” favorable and allow an organism to adapt in
changing environmental conditions and hence
Biological Markers drive evolution. Studies of these variations are
Often GV tend to be relatively stable genetically; directly relevant in understanding many features
they serve as excellent biological markers. of human populations. The structure of
Constructing a chromosome map that shows the populations in terms of inbreeding and reproduc-
positions of known genes with genetc markers tive isolation, the relationship of different
allows researchers to study and pinpoint disease populations to each other, and the geographical
traits. and historical origins of populations – all these
aspects are illuminated by studies of genetic var-
Forensic Technologies iation. Now with the advancement of next-
Genetic profiling of biological material has generation sequencing technologies, vast amount
become one of the most powerful tools for solving of data is available which is being utilized for
parental disputes and in criminal investigations. screening of genetic diseases and for designing
Traditional methods in DNA “fingerprinting” is personalized medicines. Despite of numerous
now replaced by polymerase chain reaction technical advances, many variations still may
6 Genetic Variation
exist in the genome which needs to be discovered Darwin, C. (1859). On the origin of species by means of
to fully understand the distribution, pattern, prev- natural selection, or the preservation of favoured races
in the struggle for life (1st ed.). London: John Murrey
alence, and evolution. Publication.
Izmirli, M. (2013). A literature review of MTHFR (C677T
and A1298C polymorphisms) and cancer risk. Molec-
Cross-References ular Biology Reports, 40(1), 625–637.
Kluijtmans, L. A., Van den Heuvel, L. P., Boers, G. H.,
Frosst, P., Stevens, E. M., van Oost, B. A., den Heijer,
▶ Copy Number Variant M., Trijbels, F. J., Rozen, R., & Blom, H. J. (1996).
▶ Evolution Molecular genetic analysis in mild hyper-
▶ Gene Flow homocysteinemia: A common mutation in the
methylenetetrahydrofolate reductase gene is a genetic
▶ Mutations risk factor for cardiovascular disease. American Jour-
▶ Single Nucleotide Polymorphism nal of Human Genetics, 58(1), 35.
Mugal, C. F., & Ellegren, H. (2011). Substitution rate
variation at human CpG sites correlates with non-CpG
divergence, methylation level and GC content. Genome
References Biology, 12(6), R58.
Ren, R. (2005). Mechanisms of BCR–ABL in the patho-
Botto, L. D., & Yang, Q. (2000). 5, genesis of chronic myelogenous leukaemia. Nature
10-methylenetetrahydrofolate reductase gene variants Reviews Cancer, 5(3), 172–183.
and congenital anomalies: A HuGE review. American Taylor, J. G., Choi, E. H., Foster, C. B., & Chanock, S. J.
Journal of Epidemiology, 151(9), 862–877. (2001). Using genetic variation to study human disease.
Carvalho, G. B. D., & Carvalho, G. B. D. (2011). Duffy Trends in Molecular Medicine, 7(11), 507–512.
Blood Group System and the malaria adaptation pro- Xia, J., Han, L., & Zhao, Z. (2012). Investigating the
cess in humans. Revista Brasileira de Hematologia e relationship of DNA methylation with mutation rate
Hemoterapia, 33(1), 55–64. and allele frequency in the human genome. BMC Geno-
Cutting, G. R. (2015). Cystic fibrosis genetics: From mics, 13(Suppl 8), S7.
molecular understanding to clinical application. Nature
Reviews Genetics, 16(1), 45–56.